Search Results

RAF709 5 mg  | 99.43%

TargetMol

RAF709 is a novel Raf kinase inhibitor with IC50s of 0.5 and 1.8 nM for c-Raf and b-Raf, respectively.

More Information Supplier Page

NSC632839 100 mg  | 99.87%

TargetMol

NSC632839 is a nonselective isopeptidase inhibitor, which inhibits USP2 (EC50: 45±4 μM), USP7 (EC50: 37±1 μM), and SENP2 (EC50: 9.8±1.8 μM).

More Information Supplier Page

NSC632839 10 mg  | 99.87%

TargetMol

NSC632839 is a nonselective isopeptidase inhibitor, which inhibits USP2 (EC50: 45±4 μM), USP7 (EC50: 37±1 μM), and SENP2 (EC50: 9.8±1.8 μM).

More Information Supplier Page

NSC632839 25 mg  | 99.87%

TargetMol

NSC632839 is a nonselective isopeptidase inhibitor, which inhibits USP2 (EC50: 45±4 μM), USP7 (EC50: 37±1 μM), and SENP2 (EC50: 9.8±1.8 μM).

More Information Supplier Page

NSC632839 50 mg  | 99.87%

TargetMol

NSC632839 is a nonselective isopeptidase inhibitor, which inhibits USP2 (EC50: 45±4 μM), USP7 (EC50: 37±1 μM), and SENP2 (EC50: 9.8±1.8 μM).

More Information Supplier Page

NSC632839 5 mg  | 99.87%

TargetMol

NSC632839 is a nonselective isopeptidase inhibitor, which inhibits USP2 (EC50: 45±4 μM), USP7 (EC50: 37±1 μM), and SENP2 (EC50: 9.8±1.8 μM).

More Information Supplier Page

Cyclizine hydrochloride 100 mg  | Purity Not Available

TargetMol

Cyclizine, sold under a number of brand names, is a medication used to treat and prevent nausea, vomiting and dizziness due to motion sickness or vertigo.

More Information Supplier Page

Temuterkib 10 mg  | Purity Not Available

TargetMol

LY-3214996 is a potent and selective, orally available inhibitor of the extracellular signal-regulated kinase (ERK) 1 and 2, with potential antineoplastic activity.

More Information Supplier Page